| Followers | 436 |
| Posts | 41282 |
| Boards Moderated | 0 |
| Alias Born | 10/07/2010 |
Sunday, January 19, 2020 1:18:51 PM
It’s a cult stock. Has specific shareholder only Facebook group sites (VIP and EMPIRE).
It has a shareholder specific FAQ website setup by some pharmacist. Costello is part of those sites and visits those sites.
I mentioned once before the one true asset COSTELLO has is loyal shareholders. And when he says jump they don’t ask why - they say how high.
If you hang around OTC stocks long enough loyal followers are part of the game.
I’ve seen tattoos and t-shirts eventually show up. Maybe the pharmacist will sell them all team hats.
It all depends on how effective Costello is dangling that carrot to keep them hooked. Even if it means feeding one of those NONBINDING LOI into the shell. The suspension of two of the stocks that he was involved with probably lost a few of his marks after they jumped in because he was “in the house”.But there is ALWAYS more where they came from. That is what he will count on.
It makes for good entertainment to watch it evolve even though I have seen similar schemes in the past.
It has a shareholder specific FAQ website setup by some pharmacist. Costello is part of those sites and visits those sites.
I mentioned once before the one true asset COSTELLO has is loyal shareholders. And when he says jump they don’t ask why - they say how high.
If you hang around OTC stocks long enough loyal followers are part of the game.
I’ve seen tattoos and t-shirts eventually show up. Maybe the pharmacist will sell them all team hats.
It all depends on how effective Costello is dangling that carrot to keep them hooked. Even if it means feeding one of those NONBINDING LOI into the shell. The suspension of two of the stocks that he was involved with probably lost a few of his marks after they jumped in because he was “in the house”.But there is ALWAYS more where they came from. That is what he will count on.
It makes for good entertainment to watch it evolve even though I have seen similar schemes in the past.
Recent MAJI News
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
- Exousia Pro Reports Positive Outcome in Legal Proceeding • ACCESS Newswire • 09/26/2025 02:30:00 PM
